Recall Register

Device recall: reSET Mobile App, iOS and Android, provides cognitive behavioral therapy, as part of substance abuse treatment.

Class II FDA enforcement event 88061. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Due to a software issue, patients with a urine drug screen (UDS) received access to a contingency management wheel spin for potential rewards regardless of the UDS results. Positive UDS results should not have resulted in access to a wheel spin.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Pear Therapeutics, Inc. started this device recall on 7 Jun 2021. The firm address in the FDA record is in San Francisco, CA. FDA put the recall in Class II. FDA event 88061 has 2 product records. The first FDA enforcement report date is 30 Jun 2021. The record gives the status Terminated, with the termination date 14 Jun 2023.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

U.S.: AZ, CA, DE, FL, IL, IN, KY, MA, MD, MN, NC, NY, OH, TN, WA, and WI O.U.S.: N/A

Recalling firm

Pear Therapeutics, Inc., San Francisco, CA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

2 product records in the event.

FDA event 88061: product records
Recall numberProductQuantityClassStatusReport date
Z-1925-2021reSET Mobile App, iOS and Android, provides cognitive behavioral therapy, as part of substance abuse treatment.812 unitsClass IITerminated30 Jun 2021
Z-1926-2021reSET-O Mobile App, iOS and Android, provides cognitive behavioral therapy, as part of substance abuse treatment.3,370 unitsClass IITerminated30 Jun 2021

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2021
900
Share of these events in Class II
89%
Product records in this event
2
Events of the firm on the register
1

Official channels

Cite this page

Recall Register. FDA enforcement event 88061. https://recallregister.com/fda/ii/88061/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: U.S.: AZ, CA, DE, FL, IL, IN, KY, MA, MD, MN, NC, NY, OH, TN, WA, and WI O.U.S.: N/A
What quantity of product is in FDA event 88061?
The event has 2 product records. The first record gives this quantity: 812 units
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2021 have the same class?
89% of the 900 device events that started in 2021 are in Class II.